Citrangequat
Citrangequat is a hybrid citrus fruit that is a cross between a kumquat and a citrange. It is a member of the Rutaceae family and is scientifically known as Citrus × Fortunella × Poncirus.
History[edit]
The Citrangequat was first developed in the United States in the early 20th century. It was created by Walter Tennyson Swingle, a botanist at the United States Department of Agriculture. Swingle was known for his work in creating new citrus hybrids, and the Citrangequat is one of his most successful creations.
Description[edit]
The Citrangequat is a small, round fruit that is similar in size and shape to a kumquat. It has a thin, edible skin that is bright orange when ripe. The flesh of the fruit is juicy and tart, with a flavor that is a blend of the sweet kumquat and the sour citrange. The fruit contains small, hard seeds.
Cultivation[edit]
Citrangequats are grown in a similar manner to other citrus fruits. They prefer a sunny location and well-drained soil. They are relatively hardy and can tolerate cooler temperatures than many other citrus varieties. However, they are not frost-tolerant and must be protected from freezing temperatures.
Uses[edit]
Citrangequats can be eaten fresh, but their tart flavor makes them more commonly used in cooking and baking. They are often used in marmalades, jellies, and other preserves. The fruit can also be used to flavor drinks, desserts, and savory dishes.
Varieties[edit]
There are several varieties of Citrangequat, including the 'Nippon' and the 'Thomasville'. The 'Nippon' is a larger fruit with a sweeter flavor, while the 'Thomasville' is smaller and more tart.
See also[edit]
-
Thomasville chez Swingle
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
